Results 221 to 230 of about 174,742 (304)
Dual inhibition of ERG11 and CDR2 in drug-resistant Candida albicans by Indian phytochemicals: a combined in silico-in vitro approach. [PDF]
Mundhe AK, Rajkumari R.
europepmc +1 more source
Toxicity of aqueous extracts of Ilex paraguariensis A.St.‐Hil. about Euphorbia heterophylla L.
Aqueous extracts of Ilex paraguariensis A.St.‐Hil. strongly inhibit Euphorbia heterophylla L. germination and early seedling growth, but show mild phytotoxicity on mature plants, paradoxically promoting biomass via antioxidants. Abstract BACKGROUND The escalating challenge of herbicide‐resistant weeds, exemplified by Euphorbia heterophylla L.
Tamara Alberton da Silva +8 more
wiley +1 more source
Natural Phytochemicals as Inhibitors of HIF-1α in Breast Cancer: Review of Preclinical Evidence and Future Prospects. [PDF]
Dam I, Liu E, Ali A, Madu CO, Lu Y.
europepmc +1 more source
Leaf age influences metabolomic profiling but not bioactivity of Eucalyptus globulus essential oils. Leaf age affects volatile levels of young and adult E. globulus oils, but not their bioactivity. Young leaf essential oil had higher contents of α‐ and β‐pinene. AEEO had higher levels of 1,8‐cineole and trans‐pinocarveol.
Mafalda Pinto +11 more
wiley +1 more source
Targeting Cancer Stem Cells with Phytochemicals: Molecular Mechanisms and Therapeutic Potential. [PDF]
Sah AK +8 more
europepmc +1 more source
Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee +9 more
wiley +1 more source
Phytochemicals: Principles and Practice. [PDF]
Popovic L, Rijkers GT.
europepmc +1 more source
Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley +1 more source

